Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone

Roberto Frau, Vivien Miczán, Francesco Traccis, Sonia Aroni, Csaba I. Pongor, Pierluigi Saba, Valeria Serra, Claudia Sagheddu, Silvia Fanni, Mauro Congiu, Paola Devoto, Joseph F. Cheer, István Katona, Miriam Melis

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The increased legal availability of cannabis has led to a common misconception that it is a safe natural remedy for, among others, pregnancy-related ailments such as morning sickness. Emerging clinical evidence, however, indicates that prenatal cannabis exposure (PCE) predisposes offspring to various neuropsychiatric disorders linked to aberrant dopaminergic function. Yet, our knowledge of how cannabis exposure affects the maturation of this neuromodulatory system remains limited. Here, we show that male, but not female, offspring of Δ9-tetrahydrocannabinol (THC)-exposed dams, a rat PCE model, exhibit extensive molecular and synaptic changes in dopaminergic neurons of the ventral tegmental area, including altered excitatory-to-inhibitory balance and switched polarity of long-term synaptic plasticity. The resulting hyperdopaminergic state leads to increased behavioral sensitivity to acute THC exposure during pre-adolescence. The neurosteroid pregnenolone, a US Food and Drug Administration (FDA) approved drug, rescues synaptic defects and normalizes dopaminergic activity and behavior in PCE offspring, thus suggesting a therapeutic approach for offspring exposed to cannabis during pregnancy.

Original languageEnglish
JournalNature Neuroscience
DOIs
Publication statusAccepted/In press - Jan 1 2019

Fingerprint

Pregnenolone
Dronabinol
Cannabis
Phenotype
Morning Sickness
Drug Repositioning
Pregnancy
Ventral Tegmental Area
Neuronal Plasticity
Dopaminergic Neurons
United States Food and Drug Administration
Neurotransmitter Agents

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Frau, R., Miczán, V., Traccis, F., Aroni, S., Pongor, C. I., Saba, P., ... Melis, M. (Accepted/In press). Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone. Nature Neuroscience. https://doi.org/10.1038/s41593-019-0512-2

Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone. / Frau, Roberto; Miczán, Vivien; Traccis, Francesco; Aroni, Sonia; Pongor, Csaba I.; Saba, Pierluigi; Serra, Valeria; Sagheddu, Claudia; Fanni, Silvia; Congiu, Mauro; Devoto, Paola; Cheer, Joseph F.; Katona, István; Melis, Miriam.

In: Nature Neuroscience, 01.01.2019.

Research output: Contribution to journalArticle

Frau, R, Miczán, V, Traccis, F, Aroni, S, Pongor, CI, Saba, P, Serra, V, Sagheddu, C, Fanni, S, Congiu, M, Devoto, P, Cheer, JF, Katona, I & Melis, M 2019, 'Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone', Nature Neuroscience. https://doi.org/10.1038/s41593-019-0512-2
Frau, Roberto ; Miczán, Vivien ; Traccis, Francesco ; Aroni, Sonia ; Pongor, Csaba I. ; Saba, Pierluigi ; Serra, Valeria ; Sagheddu, Claudia ; Fanni, Silvia ; Congiu, Mauro ; Devoto, Paola ; Cheer, Joseph F. ; Katona, István ; Melis, Miriam. / Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone. In: Nature Neuroscience. 2019.
@article{daea611341984b7686231dd5cad608b2,
title = "Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone",
abstract = "The increased legal availability of cannabis has led to a common misconception that it is a safe natural remedy for, among others, pregnancy-related ailments such as morning sickness. Emerging clinical evidence, however, indicates that prenatal cannabis exposure (PCE) predisposes offspring to various neuropsychiatric disorders linked to aberrant dopaminergic function. Yet, our knowledge of how cannabis exposure affects the maturation of this neuromodulatory system remains limited. Here, we show that male, but not female, offspring of Δ9-tetrahydrocannabinol (THC)-exposed dams, a rat PCE model, exhibit extensive molecular and synaptic changes in dopaminergic neurons of the ventral tegmental area, including altered excitatory-to-inhibitory balance and switched polarity of long-term synaptic plasticity. The resulting hyperdopaminergic state leads to increased behavioral sensitivity to acute THC exposure during pre-adolescence. The neurosteroid pregnenolone, a US Food and Drug Administration (FDA) approved drug, rescues synaptic defects and normalizes dopaminergic activity and behavior in PCE offspring, thus suggesting a therapeutic approach for offspring exposed to cannabis during pregnancy.",
author = "Roberto Frau and Vivien Micz{\'a}n and Francesco Traccis and Sonia Aroni and Pongor, {Csaba I.} and Pierluigi Saba and Valeria Serra and Claudia Sagheddu and Silvia Fanni and Mauro Congiu and Paola Devoto and Cheer, {Joseph F.} and Istv{\'a}n Katona and Miriam Melis",
year = "2019",
month = "1",
day = "1",
doi = "10.1038/s41593-019-0512-2",
language = "English",
journal = "Nature Neuroscience",
issn = "1097-6256",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone

AU - Frau, Roberto

AU - Miczán, Vivien

AU - Traccis, Francesco

AU - Aroni, Sonia

AU - Pongor, Csaba I.

AU - Saba, Pierluigi

AU - Serra, Valeria

AU - Sagheddu, Claudia

AU - Fanni, Silvia

AU - Congiu, Mauro

AU - Devoto, Paola

AU - Cheer, Joseph F.

AU - Katona, István

AU - Melis, Miriam

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The increased legal availability of cannabis has led to a common misconception that it is a safe natural remedy for, among others, pregnancy-related ailments such as morning sickness. Emerging clinical evidence, however, indicates that prenatal cannabis exposure (PCE) predisposes offspring to various neuropsychiatric disorders linked to aberrant dopaminergic function. Yet, our knowledge of how cannabis exposure affects the maturation of this neuromodulatory system remains limited. Here, we show that male, but not female, offspring of Δ9-tetrahydrocannabinol (THC)-exposed dams, a rat PCE model, exhibit extensive molecular and synaptic changes in dopaminergic neurons of the ventral tegmental area, including altered excitatory-to-inhibitory balance and switched polarity of long-term synaptic plasticity. The resulting hyperdopaminergic state leads to increased behavioral sensitivity to acute THC exposure during pre-adolescence. The neurosteroid pregnenolone, a US Food and Drug Administration (FDA) approved drug, rescues synaptic defects and normalizes dopaminergic activity and behavior in PCE offspring, thus suggesting a therapeutic approach for offspring exposed to cannabis during pregnancy.

AB - The increased legal availability of cannabis has led to a common misconception that it is a safe natural remedy for, among others, pregnancy-related ailments such as morning sickness. Emerging clinical evidence, however, indicates that prenatal cannabis exposure (PCE) predisposes offspring to various neuropsychiatric disorders linked to aberrant dopaminergic function. Yet, our knowledge of how cannabis exposure affects the maturation of this neuromodulatory system remains limited. Here, we show that male, but not female, offspring of Δ9-tetrahydrocannabinol (THC)-exposed dams, a rat PCE model, exhibit extensive molecular and synaptic changes in dopaminergic neurons of the ventral tegmental area, including altered excitatory-to-inhibitory balance and switched polarity of long-term synaptic plasticity. The resulting hyperdopaminergic state leads to increased behavioral sensitivity to acute THC exposure during pre-adolescence. The neurosteroid pregnenolone, a US Food and Drug Administration (FDA) approved drug, rescues synaptic defects and normalizes dopaminergic activity and behavior in PCE offspring, thus suggesting a therapeutic approach for offspring exposed to cannabis during pregnancy.

UR - http://www.scopus.com/inward/record.url?scp=85074525336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074525336&partnerID=8YFLogxK

U2 - 10.1038/s41593-019-0512-2

DO - 10.1038/s41593-019-0512-2

M3 - Article

C2 - 31611707

AN - SCOPUS:85074525336

JO - Nature Neuroscience

JF - Nature Neuroscience

SN - 1097-6256

ER -